151. CREB family: A significant role in liver fibrosis
- Author
-
Keshu Xu, Guixin Li, and Qianqian Jiang
- Subjects
0301 basic medicine ,Liver Cirrhosis ,Cirrhosis ,Inflammation ,CREB ,Biochemistry ,Extracellular matrix ,03 medical and health sciences ,Transcription (biology) ,medicine ,Hepatic Stellate Cells ,Animals ,Humans ,Cyclic AMP Response Element-Binding Protein ,Gene ,030102 biochemistry & molecular biology ,biology ,business.industry ,Binding protein ,General Medicine ,medicine.disease ,Extracellular Matrix ,030104 developmental biology ,Liver ,Cancer research ,Hepatic stellate cell ,biology.protein ,medicine.symptom ,business ,Signal Transduction - Abstract
Liver fibrosis (LF) is known as a result of the progressive accumulation of extracellular matrix (ECM), and always ascribed to chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, portal hypertension, and even multi-organ dysfunction and will bring up a health care burden worldwide. Cyclic AMP response-element binding protein (CREB), as a critical transcriptional factor, binds with conserved cAMP response-element (CRE), which is located in the promoter of targeted genes, to regulate the transcription. In the past decades, numerous studies have contributed to improved understanding of the links between CREB and liver fibrosis. In this review, we will summarize molecular mechanisms of CREB pathways and discuss contributions of CREB to liver fibrosis, focusing on activation and proliferation of hepatic stellate cells (HSCs), proliferation of cholangiocytes, deposition of extracellular matrix (ECM) and inflammation, for the development of antifibrotic therapies.
- Published
- 2019